How to cure ASD
In a study scheduled to begin in January 2021, levels of objective biomarkers are expected to be used to substantiate behavioral responses within ASD animals treated with the companies’ proprietary psilocybin drug. For one, the US FDA appears to be supportive of psilocybin research. In 2018, for example, the agency recognized psilocybin as potentially a “breakthrough therapy” for depression.
There is a rather large unmet medical need when it comes to ASD. Check disclaimer in profile.